B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLCO1B3

MOLECULAR TARGET

solute carrier organic anion transporter family member 1B3

UniProt: Q9NPD5NCBI Gene: 2823419 compounds

SLCO1B3 (solute carrier organic anion transporter family member 1B3) is targeted by 19 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLCO1B3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bilirubin1.393
2Arachidonic Acid1.102
3Genistein1.102
4Losartan1.102
5Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).1.102
6beta Carotene1.102
7candesartan cilexetil [Supplementary Concept]1.102
8Mometasone Furoate1.102
9Olmesartan Medoxomil1.102
10Ritonavir1.102
11Atorvastatin0.691
12Antimycin0.691
13Gemfibrozil0.691
14Rifamycins0.691
15Rifamycins0.691
16Silymarin0.691
17Taurocholic Acid0.691
18Triiodothyronine0.691
19Vincristine0.691

About SLCO1B3 as a Drug Target

SLCO1B3 (solute carrier organic anion transporter family member 1B3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 19 compounds with documented SLCO1B3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLCO1B3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.